SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-005640
Filing Date
2024-07-29
Accepted
2024-07-29 16:13:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3538
  Complete submission text file 0001950047-24-005640.txt   5134
Mailing Address C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Simpson Curran (Reporting) CIK: 0001346164 (see all company filings)

Type: 144

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37553 | Film No.: 241152493
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)